Innovative Therapies for Cystic Fibrosis: The Road from Treatment to Cure
Author:
Funder
Italian Cystic Fibrosis Foundation
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,Genetics,Molecular Medicine,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s40291-018-0372-6.pdf
Reference214 articles.
1. Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, Durie PR, Legrys VA, Massie J, Parad RB, Rock MJ. PW 3rd; Cystic Fibrosis Foundation. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: cystic Fibrosis Foundation consensus report. J Pediatr. 2008;153:S4–14.
2. Elborn JS. Cystic fibrosis. Lancet. 2016;388:2519–31.
3. Davis PB. Cystic fibrosis since 1938. Am J Respir Crit Care Med. 2006;173:475–82.
4. Chmiel JF, Konstan MW, Elborn JS. Antibiotic and anti-inflammatory therapies for cystic fibrosis. Cold Spring Harb Perspect Med. 2013;3:a009779.
5. Cohen-Cymberknoh M., Shoseyov D, Kerem E. Managing cystic fibrosis. Strategies to increase life expectancy and improve quality of life. Am J respir Crit Care Med 2011;183:1463.
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Virulence of Pseudomonas aeruginosa in Cystic Fibrosis: Relationships between Normoxia and Anoxia Lifestyle;Antibiotics;2023-12-19
2. Human Mesenchymal Stem Cell (hMSC) Donor Potency Selection for the “First in Cystic Fibrosis” Phase I Clinical Trial (CEASE-CF);Pharmaceuticals;2023-02-01
3. Clinical Advances in Cystic Fibrosis;Journal of Clinical Medicine;2022-10-26
4. Combined Treatment of Bronchial Epithelial Calu-3 Cells with Peptide Nucleic Acids Targeting miR-145-5p and miR-101-3p: Synergistic Enhancement of the Expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene;International Journal of Molecular Sciences;2022-08-19
5. Anticipating New Treatments for Cystic Fibrosis: A Global Survey of Researchers;Journal of Clinical Medicine;2022-02-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3